Bayer Aktiengesellschaft

Gert Streissle

Arnold Paessens

Dieter Habich

Rainer Neumann

Jutta Hansen

Jurgen Reefschlager

Hans-Joachim Zeiler

Manfred Plempel

Graham Holmwood

Peter Stadler

Oswald Lockhoff

Karl H Buchel

Karl G Metzger

Hans-Ludwig Elbe

Bernd-Wieland Kruger

Folker Lieb

Erik Regel

Udo Kraatz

Klaus Schaller

Michael Matzke

Hermann Oediger

Karl-Georg Metzger

Hein-Peter Kroll

Hartwig Muller

Klaus G Stunkel

Klaus Frobel

Helmut Brunner

Yutaka Hayauchi

Volker Klimetzek

Karl H B/u/ Chel

Peter Taylor

Karl-Heinz Weber

Thomas Henkel

Thomas-J Schulze

Thomas J Schulze

The present invention relates to novel pseudopeptides with antiviral activity of the general formula (I) ##STR1## in which the substituents have the meaning given in the description, to a process for their preparation, and to their use as antiviral agents, especially against cytomegaloviruses.

Pseudopeptides with antiviral activity

The present invention relates to valine-containing, substituted pseudopeptides of the general formula (I) ##STR1## in which the substituents have the meaning given in the description, to processes for their preparation, and to their use as anti-viral agents, in particular against cytomegaloviruses.

Valine-containing pseudopeptides with antiviral activity

The invention relates to new pseudopeptides having an antiviral action, oft he general formula (I) ##STR1## with the meanings given in the description for the substituents, to a process for their preparation and to their use as antiviral agents, in particular against cytomegaloviruses.

Pseudopeptides having an antiviral action

Compounds of the formula ##STR1## in which R.sup.1 denotes hydrogen or a saturated or singly or multiply unsaturated alkyl radical having up to 50 carbon atoms,

Novel pharmaceutically active

Compounds of the formula ##STR1## in which R.sup.1 represents an optionally substituted, straight-chain or branched, saturated, monounsaturated or polyunsaturated alkyl radical, an optionally substituted, saturated or one- or polyunsaturated cycloalkyl radical or an optionally substituted aryl radical or aralkyl radical,

Phosphorylated glycosyl-amides, -ureas, -carbamates and -thiocarbamates

The invention relates to hydroxyethylazolyl derivatives, defined herein by formula (I) and particularly to the use of said derivatives for the treatment of viral infections.

Antiviral agents

The invention relates to 2-(4-chlorophenoxymethyl)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)-2-butanol and its use for treating herpes viral infections.

Triazole derivative as an antiviral agent

The invention relates to phosphonoformic acid hydrazide compounds of the formula ##STR1## and salts thereof wherein R represents a hydrogen atom or a C.sub.1 -C.sub.6 -alkyl radical. The compounds are useful as antiviral agents, particularly against herpes viruses. Also included in the invention are processes for preparing said phosphonoformic acid hydrazide compounds, compositions and medicaments containing said phosphonoformic acid hydrazide compounds and methods for the use of said compounds and compositions.

Phosphonoformic acid hydrazide compounds, their production and their

Growing community of inventors

Wuppertal, Germany

Gert Streissle